Angelman Syndrome Alliance – Grant Call 2024
The Angelman Syndrome Alliance (ASA) is a non-profit organisation registered in the Netherlands, created by a partnership of organizations from around the world that are focused on supporting people with Angelman Syndrome, their loved ones, carers, and clinicians. By combining resources, knowledge, and a relentless dedication to initiate change, the ASA is uniquely positioned to drive advances in scientific knowledge about Angelman Syndrome. As a rare disease, funding for scientific research from major funders is limited. The ASA combines financial resources from small Angelman syndrome charities around the world to fund scientific research.
The ASA combines financial resources from small Angelman syndrome charities around the world to fund scientific research. Angelman Syndrome is a genetic disorder that results from a loss of UBE3A gene activity which encodes the ubiquitin E3 ligase E6-AP. It is characterised by severe intellectual disability, lack of speech, motor coordination deficits, sleep disturbance, and usually a happy demeanour.
Researchers of any country are invited to apply for research grants covering ‘basic science’ research that can help support a better understanding of Angelman Syndrome and eventually lead to new treatments tackling the genetic & molecular processes underlying the condition.
Applicants can apply for up to €120,000. The duration of the grant is flexible, but the maximum duration is 4 years. A detailed written report to support the evaluation of the progress of the project will be required after completion of 50% of the anticipated grant duration and a final report at the end of the study. Researchers will also be required to present their results at the ASA biannual conferences.
More details
Website : https://angelmanalliance.org/index.php/research-grants/grant-call-2024